These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33195321)

  • 21. Persistent Hypercoagulable State in COVID-19: A Case Series of COVID-19 Associated Pulmonary Embolism.
    Chan KH; Lim SL; Shaaban H; Guron G; Slim J
    J Glob Infect Dis; 2021; 13(1):38-41. PubMed ID: 33911452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentoxifylline Effects on Hospitalized COVID-19 Patients with Cytokine Storm Syndrome: A Randomized Clinical Trial.
    Sarhan RM; E Altyar A; Essam Abou Warda A; Saied YM; Ibrahim HSG; Schaalan MF; Fathy S; Sarhan N; Boshra MS
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational Cohort.
    Reyes Gil M; Gonzalez-Lugo JD; Rahman S; Barouqa M; Szymanski J; Ikemura K; Lo Y; Billett HH
    Front Physiol; 2021; 12():618929. PubMed ID: 33708136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of IL-6 in the Diagnosis, Treatment and Prognosis of COVID-19 Patients: A Longitudinal Study.
    Jain V; Kumar P; Panda PK; Suresh M; Kaushal K; Mirza AA; Raina R; Saha S; Omar BJ; Subbiah V
    Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases.
    Zhu HM; Li Y; Li BY; Yang S; Peng D; Yang X; Sun XL; Zhang M
    World J Clin Cases; 2020 Dec; 8(23):5952-5961. PubMed ID: 33344594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective Analysis of Clinical Laboratory Parameters, Therapeutics and Outcome in Patients Infected with SARS-CoV2.
    Sengupta S; Handoo A; Pande R; Kapoor RK
    Indian J Clin Biochem; 2022 Oct; 37(4):480-486. PubMed ID: 34785872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic potential of anticoagulant therapy in association with cytokine storm inhibition in severe cases of COVID-19: A case report.
    Xu Q; Wang T; Lu W
    Open Life Sci; 2021; 16(1):809-814. PubMed ID: 34485700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A label-free graphene-based impedimetric biosensor for real-time tracing of the cytokine storm in blood serum; suitable for screening COVID-19 patients.
    Khayamian MA; Parizi MS; Ghaderinia M; Abadijoo H; Vanaei S; Simaee H; Abdolhosseini S; Shalileh S; Faramarzpour M; Naeini VF; Hoseinpour P; Shojaeian F; Abbasvandi F; Abdolahad M
    RSC Adv; 2021 Oct; 11(55):34503-34515. PubMed ID: 35494759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Study of Cytokine Storm Treatment in Patients with COVID-19 Pneumonia Using Immunomodulators.
    Marc F; Moldovan CM; Hoza A; Magheru S; Ciavoi G; Farcas DM; Sachelarie L; Calin G; Romila L; Damir D; Naum AG
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35629072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death.
    Al Kharusi M; Al Sheikh N; Alhajri M; Al Mandhri SA; Khafagy ES; Moglad EH; Alotaibi HF; Hegazy WAH
    Healthcare (Basel); 2023 Apr; 11(7):. PubMed ID: 37046952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomimetic Nanoparticles Potentiate the Anti-Inflammatory Properties of Dexamethasone and Reduce the Cytokine Storm Syndrome: An Additional Weapon against COVID-19?
    Molinaro R; Pasto A; Taraballi F; Giordano F; Azzi JA; Tasciotti E; Corbo C
    Nanomaterials (Basel); 2020 Nov; 10(11):. PubMed ID: 33233748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D-dimer level elevation can aid in detection of asymptomatic COVID-19 presenting with acute cerebral infarction.
    Umemura T; Kondo H; Ohta H; Futatsuya K; Mizobe T; Yamamoto J
    eNeurologicalSci; 2021 Mar; 22():100294. PubMed ID: 33283061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Approaches for COVID-19 and Its Associated Complications.
    Wang IE; Cooper G; Mousa SA
    Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile.
    Vatsalya V; Li F; Frimodig J; Gala KS; Srivastava S; Kong M; Ramchandani VA; Feng W; Zhang X; McClain CJ
    Front Pharmacol; 2020; 11():598128. PubMed ID: 33737877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catastrophic Coronavirus Disease COVID Infection Leading to Gangrene of Foot in Peripartum Women.
    Vincent CN; Elango S; Rai D; Kumar S; Sivakumar A
    J Orthop Case Rep; 2021 Sep; 11(9):72-76. PubMed ID: 35415156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Relationship between Inflammatory Cytokines and Coagulopathy in Patients with COVID-19.
    Rad F; Dabbagh A; Dorgalaleh A; Biswas A
    J Clin Med; 2021 May; 10(9):. PubMed ID: 34065057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboinflammation response to tocilizumab in COVID-19.
    Gergi M; Cushman M; Littenberg B; Budd RC
    Res Pract Thromb Haemost; 2020 Nov; 4(8):1262-1268. PubMed ID: 33043232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review.
    Fan Y; Wang Y; Yu S; Chang J; Yan Y; Wang Y; Bian Y
    Chin Med; 2021 Jul; 16(1):67. PubMed ID: 34321065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?
    Zizzo G; Cohen PL
    Lancet Rheumatol; 2020 Dec; 2(12):e779-e790. PubMed ID: 33073244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-2 and IL-1β Patient Immune Responses Are Critical Factors in SARS-CoV-2 Infection Outcomes.
    Fawzy S; Ahmed MM; Alsayed BA; Mir R; Amle D
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.